Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Biodexa Pharmaceuticals Plc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 4 | 8 | +4 |
| Shares | 8.40K | 305.3K | +296.9K (+3,535.5%) |
| Value | $55.8K | $692.9K | +$637.1K (+1,141.0%) |
New holders (4)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 190,658 | $432.8K | 3.61% |
| Armistice Capital, LLC | 100,000 | $227.0K | 0.01% |
| HRT Financial LP | 10,583 | $24.0K | 0.00% |
| Hilton Head Capital Partners, LLC | 30 | $68 | 0.00% |
Sold out (0)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q3 2025 and filed for Q4 2025 without it.
None.